Raul Delapena Setiawan

The Mega-Merger That Might Not Be: Analyzing the AstraZeneca-BMS Rumors the-mega-merger-that-might-not-be-analyzing-the-astrazeneca-bms-rumors

the-mega-merger-that-might-not-be-analyzing-the-astrazeneca-bms-rumors

The Mega-Merger That Might Not Be: Analyzing the AstraZeneca-BMS Rumors

Raul Delapena Setiawan August 4, 2026

In the high-stakes world of global pharmaceuticals, few things command as much attention as a potential deal...

RadNet’s DeepHealth Secures FDA Clearance for AI-Powered Breast Ultrasound System: A New Era in Diagnostic Precision radnets-deephealth-secures-fda-clearance-for-ai-powered-breast-ultrasound-system-a-new-era-in-diagnostic-precision

radnets-deephealth-secures-fda-clearance-for-ai-powered-breast-ultrasound-system-a-new-era-in-diagnostic-precision

RadNet’s DeepHealth Secures FDA Clearance for AI-Powered Breast Ultrasound System: A New Era in Diagnostic Precision

Raul Delapena Setiawan August 3, 2026

In a significant leap forward for oncological imaging, DeepHealth—a subsidiary of the national diagnostic imaging leader RadNet—has...

From Patient to Provider: A Survivor’s Journey Inspires a New Generation of Nurses from-patient-to-provider-a-survivors-journey-inspires-a-new-generation-of-nurses

from-patient-to-provider-a-survivors-journey-inspires-a-new-generation-of-nurses

From Patient to Provider: A Survivor’s Journey Inspires a New Generation of Nurses

Raul Delapena Setiawan August 3, 2026

May 6th, 2026 – On National Nurses Day, we honor the unwavering dedication, profound compassion, and exceptional...

The Changing Landscape of HR-Positive Breast Cancer: Innovation, Endurance, and the Path to Precision the-changing-landscape-of-hr-positive-breast-cancer-innovation-endurance-and-the-path-to-precision

the-changing-landscape-of-hr-positive-breast-cancer-innovation-endurance-and-the-path-to-precision

The Changing Landscape of HR-Positive Breast Cancer: Innovation, Endurance, and the Path to Precision

Raul Delapena Setiawan August 2, 2026

The landscape of oncology is shifting from broad-spectrum interventions to a sophisticated, molecular-targeted approach. At the forefront...

The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine the-genomic-frontier-how-the-broad-institute-is-rewriting-the-future-of-medicine

the-genomic-frontier-how-the-broad-institute-is-rewriting-the-future-of-medicine

The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine

Raul Delapena Setiawan August 2, 2026

For decades, the promise of genomic medicine—the ability to diagnose, treat, and potentially cure diseases by editing...

Moderna’s Norovirus Vaccine Trial Continues Blinded as New Cohort Enrollment Begins Following Interim Analysis modernas-norovirus-vaccine-trial-continues-blinded-as-new-cohort-enrollment-begins-following-interim-analysis

modernas-norovirus-vaccine-trial-continues-blinded-as-new-cohort-enrollment-begins-following-interim-analysis

Moderna’s Norovirus Vaccine Trial Continues Blinded as New Cohort Enrollment Begins Following Interim Analysis

Raul Delapena Setiawan August 2, 2026

Cambridge, MA – Moderna, a prominent biotechnology company, is set to expand its Phase III clinical trial...

The Art of the Twist: Unlocking Liberation through Ardha Matsyendrasana the-art-of-the-twist-unlocking-liberation-through-ardha-matsyendrasana

the-art-of-the-twist-unlocking-liberation-through-ardha-matsyendrasana

The Art of the Twist: Unlocking Liberation through Ardha Matsyendrasana

Raul Delapena Setiawan August 2, 2026

Introduction: The Hidden Depths of the Spine In the vast landscape of Hatha Yoga, few postures possess...

The Next Frontier in Precision Oncology: Why Merck’s Calderasib is Redefining KRAS Inhibition the-next-frontier-in-precision-oncology-why-mercks-calderasib-is-redefining-kras-inhibition

the-next-frontier-in-precision-oncology-why-mercks-calderasib-is-redefining-kras-inhibition

The Next Frontier in Precision Oncology: Why Merck’s Calderasib is Redefining KRAS Inhibition

Raul Delapena Setiawan August 2, 2026

For decades, the KRAS gene—a critical driver of cellular growth—was considered the "Holy Grail" of oncology, yet...

Dexcom’s Strategic Pivot: Market Optimism and Long-Term Growth Following Strong Q2 Performance dexcoms-strategic-pivot-market-optimism-and-long-term-growth-following-strong-q2-performance

dexcoms-strategic-pivot-market-optimism-and-long-term-growth-following-strong-q2-performance

Dexcom’s Strategic Pivot: Market Optimism and Long-Term Growth Following Strong Q2 Performance

Raul Delapena Setiawan August 1, 2026

The global medical technology landscape is currently witnessing a significant shift in the management of diabetes, a...

Inflammatory Setback: Novo Nordisk’s Ziltivekimab Failure Sends Shockwaves Through Cardiovascular Biotech inflammatory-setback-novo-nordisks-ziltivekimab-failure-sends-shockwaves-through-cardiovascular-biotech

inflammatory-setback-novo-nordisks-ziltivekimab-failure-sends-shockwaves-through-cardiovascular-biotech

Inflammatory Setback: Novo Nordisk’s Ziltivekimab Failure Sends Shockwaves Through Cardiovascular Biotech

Raul Delapena Setiawan August 1, 2026

By Jonathan Gardner Published July 31, 2026 The landscape of cardiovascular medicine faced a significant recalibration this...